Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics.

Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract.

Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract.

Entera’s Proprietary Technologies Act Synergistically to Transport and Protect Large Molecules.